These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9294665)

  • 21. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients.
    Mercando AD; Aronow WS; Epstein S; Fishbach M
    Am J Cardiol; 1995 Sep; 76(7):436-40. PubMed ID: 7653440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
    Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
    Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of sudden death risk factors in acute and chronic coronary artery disease.
    Vismara LA; Vera Z; Foerster JM; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 May; 39(6):821-8. PubMed ID: 871108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction.
    Rodríguez LM; Sternick EB; Smeets JL; Timmermans C; den Dulk K; Oreto G; Wellens HJ
    Heart; 1996 Jan; 75(1):23-8. PubMed ID: 8624866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure.
    Singh BN
    Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of sudden death and spontaneous ventricular tachycardia in survivors of complicated myocardial infarction: value of the response to programmed stimulation using a maximum of three ventricular extrastimuli.
    Waspe LE; Seinfeld D; Ferrick A; Kim SG; Matos JA; Fisher JD
    J Am Coll Cardiol; 1985 Jun; 5(6):1292-301. PubMed ID: 2582016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?
    Sarter BH; Finkle JK; Gerszten RE; Buxton AE
    J Am Coll Cardiol; 1996 Jul; 28(1):122-9. PubMed ID: 8752804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Programmed ventricular stimulation in detecting malignant ventricular arrhythmia following myocardial infarct].
    Klein H
    Internist (Berl); 1987 Mar; 28(3):151-8. PubMed ID: 3294721
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
    Piccini JP; Schulte PJ; Pieper KS; Mehta RH; White HD; Van de Werf F; Ardissino D; Califf RM; Granger CB; Ohman EM; Alexander JH
    Crit Care Med; 2011 Jan; 39(1):78-83. PubMed ID: 20959785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined evaluation of ambulatory-based late potentials and nonsustained ventricular tachycardia to predict arrhythmic events in patients with previous myocardial infarction: A Japanese noninvasive electrocardiographic risk stratification of sudden cardiac death (JANIES) substudy.
    Hashimoto K; Amino M; Yoshioka K; Kasamaki Y; Kinoshita T; Ikeda T
    Ann Noninvasive Electrocardiol; 2021 Jan; 26(1):e12803. PubMed ID: 32969113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of ventricular arrhythmias].
    Vergara G
    Ital Heart J Suppl; 2001 Dec; 2(12):1291-5. PubMed ID: 11838350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Congestive heart failure and arrhythmia].
    Kasanuki H
    Nihon Rinsho; 1993 May; 51(5):1354-61. PubMed ID: 8101240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification and management of patients with organic heart disease and nonsustained ventricular tachycardia: role of programmed stimulation, left ventricular ejection fraction, and the signal-averaged electrocardiogram.
    Turitto G; Fontaine JM; Ursell S; Caref EB; Bekheit S; el-Sherif N
    Am J Med; 1990 Jan; 88(1N):35N-41N. PubMed ID: 2368762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk factors and prevention of sudden cardiac death in patients with ventricular tachycardia after myocardial infarct].
    Kaliská G; Szentiványi M; Kmec P; Alberty R
    Vnitr Lek; 1999 Jan; 45(1):22-9. PubMed ID: 10422522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment, significance and mechanism of ventricular electrical instability after myocardial infarction.
    Richards DA; Denniss AR
    Heart Lung Circ; 2007 Jun; 16(3):149-55. PubMed ID: 17446130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation.
    Maury P; Zimmermann M; Metzger J; Reynard C; Dorsaz P; Adamec R
    Int J Cardiol; 2000; 76(2-3):199-210. PubMed ID: 11104875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
    Block M; Hammel D; Böcker D; Borggrefe M; Breithardt G
    Am J Cardiol; 1996 Sep; 78(5A):62-8. PubMed ID: 8820838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.